News wire
Mass torts and MDLs
Multidistrict litigation, bellwether trials and mass tort dockets.
Source check 13 min ago · Newest item 7 hr ago · 1,441 stories this week · 87 of 90 publishers answering · Browse publishers · RSS feed
Filter stories (1)
Saved on this browser
Mass torts and MDLs
Monday, November 16
Teva, Actavis Near Deal In States' Generic-Drug Pricing MDL
Meta's 'Privilege Abuse' Warrants Sanctions, MDL Judge Told
Simmons Hanly Conroy Earns 2027 Best Law Firms® Rankings
ALTON, Ill. – Simmons Hanly Conroy , one of the nation’s largest mass tort law firms and a national leader in the legal representation of mesothelioma patients and their families, is pleased to announce its inclusion in the 2027 edition of Best Law Firms®, earning recognition nationally and regionally across several practice areas. The firm was recognized among the Best Law Firms in 1 national practice area and regionally in 5 practice areas. Published annually by Best Lawyers®, the guide highlights only the top 3.8% of law firms nationwide. “Being named to Best Law Firms once again, at both…
3M agrees to $7.35B settlement over PFAS firefighting foam injury claims
Hernia Mesh Failure Lawsuit Claims Covidien Symbotex Implant Caused Bowel Obstruction
Ozempic and Vision Loss: What the FDA’s New NAION Warning Means in Illinois
On November 9, 2026, the FDA ordered every company that sells a GLP-1 drug to add a new warning to its label: a possible increased risk of NAION, a rare eye condition that can cause sudden and sometimes permanent vision loss. The order covers Ozempic, Wegovy, Mounjaro, Zepbound and every other GLP-1 on the market.... Continue Reading
Sunday, November 15
Blanket Workplace Bans on Prescribed Opioid Treatment Puts Employer in EEOC’s Crosshairs
Friday, November 13
NetChoice Sues To Halt NY's Social Media Warning Law
Roundup User Says Justices' Ruling Doesn't Bar His Claims
Illinois Medicaid Filled Nearly 1 Million Prescriptions for Leading GLP-1 Drugs Before the FDA’s Vision Loss Warning
Illinois Medicaid paid for 993,119 prescriptions for nine leading GLP-1 drugs between 2022 and 2025, at a gross cost of $1.1 billion. Every one was filled before November 9, 2026, when the FDA ordered manufacturers to add a warning about a rare form of permanent vision loss called NAION. Ankin Law analyzed four years of... Continue Reading
Port Catheter Lawsuit Links SmartPort to Infections, Sepsis
Thursday, November 12
3 Vape Distributors Reach Deal To Flee Price-Fixing MDL
TikTok Backs School District In MDL Trial Witness Fight
What Meta and TikTok Paid Teens in Social Media Addiction Cases
Instagram, Roblox and Snapchat Lawsuit Alleges Online Grooming Forced Family to Move After Threats
Bard PowerPort Lawsuit Update on the MDL 3081 Trials
Wednesday, November 11
FDA Orders New GLP-1 Risk Warnings Over Vision Loss
Read at Law360 Product Liability 3 publishers · 3 reports
She Did Everything Right. She Just Wanted to Get Home.
She Did Everything Right. She Just Wanted to Get Home.
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials
Dupixent CTCL Lawsuits Can Be Directly Filed in Federal MDL
AirTag stalking litigation raises design questions
AngioDynamics Port Lawsuits Reach 450 as Test Cases Take Shape
Tuesday, November 10
Cartiva Implant Lawsuit
26 Simmons Hanly Conroy Attorneys Selected for 2026 National Trial Lawyers Membership
ALTON, Ill. – Simmons Hanly Conroy , one of the nation’s largest mass tort law firms and a national leader in the legal representation of mesothelioma patients and their families, is pleased to announce that 26 of its attorneys have been selected for 2026 membership in The National Trial Lawyers, including its Top 100, Top 40 Under 40, and Specialty Association divisions. The National Trial Lawyers is an invitation-only professional organization founded in 2008. Its Top 100 and Top 40 Under 40 are membership designations organized by state or region. Selection is based on a multi-phase…
STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
Judge Again Declines Recusal Over Wife's Blank Rome Ties
Cartiva Lawsuits Over Toe Implant Problems Moving Forward in Federal MDL
Judge Will Reduce 'Shocking' $88M Mesh Bellwether Verdict
Connect the news to your market.
Research the firms, offices and conference relationships behind the headlines.